Preop RT May Boost Response to Chemo-Immunotherapy in High-Risk Early Breast Cancer

(MedPage Today) — SAN ANTONIO — Preoperative radiotherapy (RT) plus PD-1 inhibitor pembrolizumab (Keytruda) significantly increased immune activation and tumor response in node-positive hormone receptor-positive (HR+)/HER2-negative breast cancer…

Source link : https://www.medpagetoday.com/meetingcoverage/sabcs/119006

Author :

Publish date : 2025-12-14 22:21:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Preop RT May Boost Response to Chemo-Immunotherapy in High-Risk Early Breast Cancer

‘Terrible Distortion of All the Facts’: What We Heard This Week

Related Posts

‘Terrible Distortion of All the Facts’: What We Heard This Week

I Co-Discovered HIV. Here Are Lessons to Help Prepare for the Next Threat.

Popular Holiday Beverages High In Sugar May Cause Damage

No Increased Breast Cancer Risk With Menopausal Estrogen in BRCA Carriers

How Were GLP-1 Drugs and Bone Health Linked?

Pain and Functioning; AI Decision Support for Stroke Treatment

Preop RT May Boost Response to Chemo-Immunotherapy in High-Risk Early Breast Cancer

‘Terrible Distortion of All the Facts’: What We Heard This Week

I Co-Discovered HIV. Here Are Lessons to Help Prepare for the Next Threat.

Popular Holiday Beverages High In Sugar May Cause Damage

No Increased Breast Cancer Risk With Menopausal Estrogen in BRCA Carriers

How Were GLP-1 Drugs and Bone Health Linked?

Pain and Functioning; AI Decision Support for Stroke Treatment

Fragile Students Won’t Last in Medicine

Categories

Archives